secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moringa Acquisition Corp (—)
CIK:        0001835416
Form:       8-K
Filed at:   2024-04-03T23:59:59+00:00
Accession:  0001213900-24-029646
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moringa restructures Silexion business combination at $62.5M valuation; new public entity Biomotion Sciences
--------------------------------------------------------------------------------

- A&R BCA inserts Biomotion Sciences as new public TopCo; Moringa and Silexion to become subsidiaries.
- Pre-transaction equity value of Silexion remains $62.5M ($10/share).
- SPAC sponsor must forfeit 2.875M founder shares and invest at least $350k in TopCo.
- Silexion must raise at least $3.5M by April 30, 2024; deal can be terminated if not met.
- Termination date August 19, 2024; no termination fees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835416/000121390024029646/0001213900-24-029646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835416/000121390024029646/ea0203204-8k_moringa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-029646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer